{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    9,
    13,
    14,
    81
  ],
  "modelUsed": "gemini-3-flash-preview",
  "advanced": {
    "studyAmendments": [
      {
        "id": "amend_1",
        "number": "1.0",
        "name": "Amendment 1.0",
        "scope": {
          "id": "6cec4974-8a8e-4073-a040-69ea24c4e0c0",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "01c1b33e-8ba6-48ce-938a-1345b06293ca",
          "code": {
            "id": "5713752f-7e3b-4afa-8da7-f64f61e591ad",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "c2dbf2b6-fc4b-4878-98c8-9999adc302a2",
            "type": {
              "id": "1458d93e-c227-4fda-9b7b-386249b46b09",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "Initial creation of the clinical study protocol.",
        "effectiveDate": "2016-10-26",
        "reasonIds": [
          "ar_1_1"
        ],
        "newVersion": "1.0"
      },
      {
        "id": "amend_2",
        "number": "2.0",
        "name": "Amendment 2.0",
        "scope": {
          "id": "f59fab6a-43c2-41d4-aebe-243041142610",
          "code": "Global",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Global",
          "instanceType": "Code"
        },
        "primaryReason": {
          "id": "6c1b6580-c904-4a90-a9e3-2d21479f4937",
          "code": {
            "id": "707734fd-898f-4b50-b8e5-21a7b8b623f7",
            "code": "C98782",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Protocol Amendment",
            "instanceType": "Code"
          },
          "otherReason": "Protocol Amendment",
          "instanceType": "StudyAmendmentReason"
        },
        "geographicScopes": [
          {
            "id": "614e8ced-2e6d-422e-91a7-fb602066b52f",
            "type": {
              "id": "b240b9f7-6dfd-42f1-8c97-74f851601ae5",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "instanceType": "GeographicScope"
          }
        ],
        "instanceType": "StudyAmendment",
        "summary": "The main reasons for preparation of this amendment were to expand the adverse event of interest category for amputations based on regulatory discussion, incorporate an Echocardiographic Sub-study, update the KCCQ secondary objective, and clarify exclusion criteria and contraceptive requirements to harmonise with informed consent. Additionally, it simplifies SAE reporting by limiting withheld event types to HF and fatal AEs to minimize risk of withholding renal AEs.",
        "effectiveDate": "2017-10-25",
        "reasonIds": [
          "ar_2_1",
          "ar_2_2",
          "ar_2_3",
          "ar_2_4"
        ],
        "previousVersion": "1.0",
        "newVersion": "2.0"
      }
    ],
    "amendmentReasons": [
      {
        "id": "ar_1_1",
        "code": "ADMINISTRATIVE",
        "description": "Administrative",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_1",
        "code": "REGULATORY",
        "description": "Regulatory",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_2",
        "code": "SAFETY",
        "description": "Safety",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_3",
        "code": "SCIENTIFIC",
        "description": "Scientific",
        "instanceType": "AmendmentReason"
      },
      {
        "id": "ar_2_4",
        "code": "OPERATIONAL",
        "description": "Operational",
        "instanceType": "AmendmentReason"
      }
    ],
    "countries": [
      {
        "id": "country_1",
        "name": "United Kingdom",
        "instanceType": "Country",
        "code": "GB"
      },
      {
        "id": "country_2",
        "name": "Sweden",
        "instanceType": "Country",
        "code": "SE"
      }
    ],
    "studySites": [
      {
        "id": "site_1",
        "name": "Site 1",
        "instanceType": "StudySite",
        "countryId": "country_1",
        "city": "Glasgow"
      }
    ],
    "summary": {
      "amendmentCount": 2,
      "countryCount": 2,
      "siteCount": 1
    },
    "geographicScope": {
      "id": "geo_1",
      "name": "Study Geographic Scope",
      "scopeType": "International",
      "instanceType": "GeographicScope",
      "countryIds": [
        "country_1",
        "country_2"
      ]
    }
  },
  "rawResponse": {
    "amendments": [
      {
        "number": "1.0",
        "effectiveDate": "2016-10-26",
        "summary": "Initial creation of the clinical study protocol.",
        "previousVersion": null,
        "newVersion": "1.0",
        "reasons": [
          "Administrative"
        ]
      },
      {
        "number": "2.0",
        "effectiveDate": "2017-10-25",
        "summary": "The main reasons for preparation of this amendment were to expand the adverse event of interest category for amputations based on regulatory discussion, incorporate an Echocardiographic Sub-study, update the KCCQ secondary objective, and clarify exclusion criteria and contraceptive requirements to harmonise with informed consent. Additionally, it simplifies SAE reporting by limiting withheld event types to HF and fatal AEs to minimize risk of withholding renal AEs.",
        "previousVersion": "1.0",
        "newVersion": "2.0",
        "reasons": [
          "Regulatory",
          "Safety",
          "Scientific",
          "Operational"
        ]
      }
    ],
    "geographicScope": {
      "type": "International",
      "countries": [
        {
          "name": "United Kingdom",
          "code": "GB"
        },
        {
          "name": "Sweden",
          "code": "SE"
        }
      ],
      "regions": [],
      "plannedSites": 600
    },
    "sites": [
      {
        "siteName": "University of Glasgow",
        "city": "Glasgow",
        "country": "United Kingdom"
      }
    ]
  }
}